Ironwood Pharmaceuticals Inc (IRWD)
- Exchange
- NASDAQ
- Symbol
- IRWD
- Sector
- Life Sciences
- Industry
- Pharmaceutical Preparations
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. The company is headquartered in Boston, Massachusetts.
- Country
- USA
Stock price
At close: November 22, 2024
-
Open3.33
-
High3.50
-
Low3.26
-
Close3.44
-
Volume1,774,220
Financial ratios
Dec 31, 2023
Activity ratios
Liquidity ratios
Solvency ratios
Profitability ratios
Inventory turnover
—
Receivables turnover
3.33
Payables turnover
20.30
Working capital turnover
—
Days of inventory on hand (DOH)
—
Days of sales outstanding (DSO)
109.72
Number of days of payables
17.98
Fixed asset turnover
76.91
Total asset turnover
0.91
Current ratio
0.84
Quick ratio
0.80
Cash ratio
0.33
Cash conversion cycle
91.74
Debt-to-assets ratio
1.06
Debt-to-capital ratio
3.28
Debt-to-equity ratio
—
Financial leverage ratio
—
Interest coverage
-41.48
Gross profit margin
72.15%
Operating profit margin
-220.10%
Pretax margin
-213.89%
Net profit margin
-233.32%
Operating return on assets (Operating ROA)
-200.70%
Return on assets (ROA)
-212.76%
Return on total capital
-590.16%
Return on equity (ROE)
—